Replies to post #259226 on Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

"Here Bavituximab is the key to SOC for the BPs that otherwise compete against each other with the same type of molecules for the same conditions (cancers)."

The key that cannot go thru one trial where it succeeds without question. WS does not share your enthusiasm to put it mildly.

[BCS Paladin]

And Bavituximab is not a drug pipeline that is new and needs the PI again. See clinicaltrials.gov, with a direct PII trial with Durvalumab of AstraZeneca

.


Now this is exciting.

2-3 years in Phase II before FDA says Phase III ok.

3-4 years to get through Phase III and the FDA telling us we can finally sell something.

During 5-7 years the BP's will probably have spent 50 billion on R&D to make Bavi USELESS.

As it stands now this company is in DEEP TROUBLE